Stocks
GlaxoSmithKline (GSK) OPEX US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OPEX, £ | 12 176 000 000 | 13 337 000 000 | 15 018 000 000 | 18 307 000 000 | 15 312 000 000 | 15 410 000 000 | |||
| Changes by years, y/y, % | +17% | +10% | +13% | +22% | -16% | +7.9% | |||
GlaxoSmithKline. OPEX, £
GlaxoSmithKline. OPEX, changes, %
GlaxoSmithKline. OPEX, sum by quarters, £
GlaxoSmithKline (GSK) OPEX US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| OPEX, £ | 3 363 000 000 | 3 798 000 000 | 3 696 000 000 | 4 455 000 000 | 3 461 000 000 | 15 410 000 000 | ||
| Changes by years, y/y, % | -14% | -8% | -32% | -8% | +3% | |||
| Changes by quarters, q/q, % | -31% | +13% | -3% | +21% | -22% | |||
